Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1985 Mar;27(3):422-3.
doi: 10.1128/AAC.27.3.422.

Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections

E J Goldstein, M L Alpert, B P Ginsberg
Clinical Trial

Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections

E J Goldstein et al. Antimicrob Agents Chemother. 1985 Mar.

Abstract

In a prospective, randomized trial, norfloxacin (400 mg perorally, twice a day) was compared with trimethoprim-sulfamethoxazole (160-800 mg perorally, twice a day) in 45 patients with uncomplicated urinary tract infections. Escherichia coli was the most common isolate. Infections due to Enterobacter spp., Proteus mirabilis, Pseudomonas spp., and Staphylococcus spp. were also treated. Norfloxacin was equivalent in effectiveness and safety to trimethoprim-sulfamethoxazole, with a cure rate of 91% at the 5- to 9-day posttherapy visit and 88% at the 4- to 6-week posttherapy visit. It was well tolerated and had a low incidence of side effects.

PubMed Disclaimer

References

    1. Antimicrob Agents Chemother. 1982 Apr;21(4):604-7 - PubMed
    1. Antimicrob Agents Chemother. 1982 Apr;21(4):670-2 - PubMed
    1. Antimicrob Agents Chemother. 1982 May;21(5):808-10 - PubMed
    1. Antimicrob Agents Chemother. 1982 May;21(5):848-51 - PubMed
    1. N Engl J Med. 1982 Sep 9;307(11):637-42 - PubMed

Publication types

MeSH terms